Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells

Journal of Mammary Gland Biology and Neoplasia

Volumn 5, Issue 3, 2000, Pages 295-306

  Safe, S ^a   Wormke, M ^a   Samudio, I ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Ah receptor; ER ; Inhibitory crosstalk

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTINEOPLASTIC AGENT; AROMATIC HYDROCARBON RECEPTOR; CATHEPSIN D; DIOXIN; DNA; ESTRADIOL; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN 27; LIGAND; NUCLEAR PROTEIN; PROTEIN C FOS; PROTEIN PS2; SELECTIVE AROMATIC HYDROCARBON RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER CELL CULTURE; COMPLEX FORMATION; DISEASE MODEL; DNA TRANSCRIPTION; GENE EXPRESSION; GENETIC ANALYSIS; GROWTH INHIBITION; HUMAN; IN VIVO STUDY; INHIBITION KINETICS; MAMMARY GLAND; MOLECULAR INTERACTION; NONHUMAN; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; REVIEW; TRANSACTIVATION; TUMOR GROWTH; UTERUS;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYSTEINE ENDOPEPTIDASES; DIOXINS; DNA; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; MALE; MAMMARY NEOPLASMS, ANIMAL; MODELS, BIOLOGICAL; MULTIENZYME COMPLEXES; PROMOTER REGIONS (GENETICS); PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; TETRACHLORODIBENZODIOXIN; TIME FACTORS; TRANS-ACTIVATION (GENETICS);

EID: 0034485357     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009550912337     Document Type: Review

References (75)

1. Breast cancer trends. Incidence, mortality, and survival
2. Steroid hormones and risk of breast cancer
3. Epidemiologic analysis of breast and gynecologic cancers
4. Toward a unified concept of mammary carcinogenesis
5. Molecular mechanisms of antiestrogen action in breast cancer
6. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds
7. Antiestrogenic activity of TCDD and related compounds
8. Estrogenic and antiestrogenic compounds
9. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related environmental antiestrogens: Characterization and mechanism of action
10. Development of selective aryl hydrocarbon receptor modulators (SARMs) for treatment of breast cancer
11. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol: Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase
12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons. Examinations of the mechanism of toxicity
13. The steroid and thyroid hormone receptor superfamily
14. cDNA cloning and structure of the putative Ah receptor
15. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor
16. Cloning of a factor required for activity of the Ah (dioxin) receptor
17. Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses
18. Interactions of ARNT with AhR and HIF-1α
19. Two forms of aryl hydrocarbon receptor type 2 in rainbow trout (Oncorhynchus mykiss). Evidence for differential expression and enhancer specificity
20. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT
21. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor
22. Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development
23. Induction of cytochrome P4501A1: A model for analyzing mammalian gene transcription
24. CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt)
25. Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex
26. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors: Absence of a role for LXXLL motifs
27. Results of a 2-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats
28. Inhibition of 7,12-dimethyl-benzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin
29. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats
30. 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6 mice
31. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced porphyria in genetically inbred mice: Partial antagonism and mechanistic studies
32. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: Inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities
33. 6-Alkyl-1,3,8-trichlorodibenzofurans as antiestrogens in female Sprague-Dawley rats
34. 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as an antiestrogen in human and rodent cancer cell lines: Evidence for the role of the Ah receptor
35. Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: Structure-activity studies
36. Antiestrogenic activities of alternate substituted polychlorinated dibenzofurans in MCF-7 human breast cancer cells
37. Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor growth by aryl hydrocarbon receptor agonists
38. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo - Comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin
39. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells
40. Aryl hydrocarbon receptor-mediated antiestrogenic and anti-tumorigenic activity of diindolylmethane
41. Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780
42. Continuous exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibits the growth of surgically induced endometriosis in the ovariectomized mouse treated with high dose estradiol
43. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis
44. Increased oxidative DNA damage in livers of 2,3,7,8-tetrachlorodibenzo-p-dioxin treated intact but not ovariectomized rats
45. Prenatal TCDD and predisposition to mammary cancer in the rat
46. Suppression of estrogen-regulated extracellular plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin
47. Inhibition of postconfluent focus production in cultures of MCF-7 breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin
48. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160- kDa proteins in human breast cancer cells
49. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: Quantitative structure-activity relationships
50. Development of gel staining techniques for detecting the secretion of procathepsin D (52-kDa protein) in MCF-7 human breast cancer cells
51. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells
52. Interaction of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 12-O-tetradecanoylphorbol-13-acetate (TPA) and 17β-estradiol in MCF-7 human breast cancer cells
53. 13C-nuclear magnetic resonance studies
54. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression
55. Inhibition of prolactin receptor gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 human breast cancer cells
56. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: Modulation of hormone-induced cell cycle enzymes
57. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds on the occupied nuclear estrogen receptor in MCF-7 human breast cancer cells
58. Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells
59. R) human breast cancer cells: A unique aryl hydrocarbon (Ah)-nonresponsive clone
60. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor
61. The aryl hydrocarbon receptor interacts with estrogen receptor α and orphan receptors COUP-TFI and ERRα1
62. Proteasome-dependent degradation of the human estrogen receptor
63. Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytoplasmic proteasome following nuclear export
64. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in MCF-7 breast cancer cells: Identification of genes downregulated by AhR agonists using suppression subtractive hybridization
65. Functional synergy between the transcription factor Sp1 and the estrogen receptor
66. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: Role of estrogen receptor Sp1 complex formation
67. Functional and physical interactions between the estrogen receptor-Sp1 and the nuclear aryl hydrocarbon receptor complexes
68. Estrogen-induced retinoic acid receptor α1 gene expression: Role of estrogen receptor-Sp1 complex
69. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: Role of estrogen receptor-Sp1 interactions
70. Transcriptional activation of insulin-like growth factor biding protein 4 by 17β-estradiol in MCF-7 cells: Role of estrogen receptor-Sp1 complexes
71. Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions
72. Identification of a motif within the 5′-regulatory region on pS2 which is responsible for Ap1 binding and TCDD-mediated suppression
73. The price of repression
74. Transcriptional activation of c-fos protooncogene by 17β-estradiol: Mechanism of aryl hydrocarbon receptor-mediated inhibition
75. 3,3′,4,,4′-Tetrachlorobiphenyl exhibits anti-estrogenic and antitumorigenic activity in the rodent uterus and mammary and in human breast cancer cells